Dr. Aaron Reliford
Claim this profileClinical Trials Aaron Reliford is currently running
More about Aaron Reliford
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Aaron Reliford has experience with
- Trauma Focused CBT (TF-CBT)
- Trauma Systems Therapy (TST)
Breakdown of trials Aaron Reliford has run
Post-Traumatic Stress Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aaron Reliford specialize in?
Aaron Reliford focuses on Post-Traumatic Stress Disorder and other conditions. In particular, much of their work with Post-Traumatic Stress Disorder has involved treating patients, or patients who are undergoing treatment.
Is Aaron Reliford currently recruiting for clinical trials?
Yes, Aaron Reliford is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Aaron Reliford has studied deeply?
Yes, Aaron Reliford has studied treatments such as Trauma Focused CBT (TF-CBT), Trauma Systems therapy (TST).
What is the best way to schedule an appointment with Aaron Reliford?
Apply for one of the trials that Aaron Reliford is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.